All terms in GO

Label Id Description
RNA polymerase II C-terminal domain phosphoserine binding GO_1990269 [Binding to phosphorylated serine residues in the C-terminal domain of RNA polymerase II.]
RNA polymerase II C-terminal domain binding GO_0099122 [Binding to the C-terminal domain (CTD) of the largest subunit of RNA polymerase II. The CTD is comprised of repeats of a heptapeptide with the consensus sequence YSPTSPS. The number of repeats varies with the species and a minimum number of repeats is required for RNAP II function.]
phosphoserine residue binding GO_0050815 [Binding to a phosphorylated serine residue within a protein.]
neutrophil migration GO_1990266 [The movement of a neutrophil within or between different tissues and organs of the body.]
granulocyte migration GO_0097530 [The movement of a granulocyte within or between different tissues and organs of the body.]
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity GO_1990264 [Any peptidyl-tyrosine dephosphorylation that is involved in inactivation of protein kinase activity.]
peptidyl-tyrosine dephosphorylation GO_0035335 [The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.]
platelet-derived growth factor complex GO_1990265 [A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerization and activation. PDGFs are involved in a wide variety of signaling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).]
anti-Mullerian hormone receptor signaling pathway GO_1990262 [The series of molecular signals initiated by the binding of anti-Mullerian hormone to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Upon ligand binding, the receptor forms a complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators.]
cell surface receptor protein serine/threonine kinase signaling pathway GO_0007178 [The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription.]
obsolete spore wall assembly MAPK cascade GO_1990263 [OBSOLETE. A MAPK cascade that occurs as a result of deprivation of nourishment.]
obsolete negative regulation of transcription from RNA polymerase II promoter by transcription factor localization involved in response to DNA damage checkpoint signaling GO_1990260 [OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter using a mechanism that involves the localization of a transcription factor and initiated in response to the DNA damage checkpoint signaling.]
positive regulation of anterior head development GO_2000744 [Any process that activates or increases the frequency, rate or extent of anterior head development.]
regulation of anterior head development GO_2000742 [Any process that modulates the frequency, rate or extent of anterior head development.]
pre-mRNA catabolic process GO_1990261 [The chemical reactions and pathways resulting in the breakdown of the unspliced pre-mRNA (pre-messenger RNA).]
obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation GO_2000745 [OBSOLETE. Any positive regulation of transcription from RNA polymerase III promoter that is involved in smooth muscle cell differentiation.]
negative regulation of anterior head development GO_2000743 [Any process that stops, prevents or reduces the frequency, rate or extent of anterior head development.]
positive regulation of defecation rhythm GO_2000748 [Any process that activates or increases the frequency, rate or extent of defecation rhythm.]
positive regulation of defecation GO_2000294 [Any process that activates or increases the frequency, rate or extent of defecation.]
regulation of defecation rhythm GO_2000746 [Any process that modulates the frequency, rate or extent of defecation rhythm.]